BROADWOOD CAPITAL INC Long-Term Concentrated

CIK: 0001278387 · Show all filings

Period: Q3 2019 (← Previous) (Next →)

Filing Date: Nov 14, 2019

Total Value ($000): $720,376 (100.0% shares, 0.0% debt)

Holdings (7)

STAA STAAR SURGICAL CO 38.8%

Value ($000) $279,471 Shares 10,840,630 Est. Cost $8.21 Unrealized +270.2%

MNST MONSTER BEVERAGE CORP NEW 37.7%

Value ($000) $271,681 Shares 4,679,308 Est. Cost $22.71 Unrealized +33.4%

IWM ISHARES TR 8.8%

Value ($000) $63,563 Shares 420,000 Est. Cost $109.78 Unrealized —

AXON AXON ENTERPRISE INC 6.0%

Value ($000) $43,156 Shares 760,062 Est. Cost $27.50 Unrealized +129.5%

LCTX LINEAGE CELL THERAPEUTICS IN 4.6%

Value ($000) $33,325 Shares 34,005,379 Est. Cost $1.03 Unrealized 0.0%

— ONCOCYTE CORPORATION 3.2%

Value ($000) $23,306 Shares 11,098,267 Est. Cost $3.42 Unrealized —

— AGEX THERAPEUTICS INC 0.8%

Value ($000) $5,874 Shares 2,997,156 Est. Cost $2.99 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
STAA	STAAR SURGICAL CO	10,840,630	$279,471	38.8%	$8.21	+270.2%	COM PAR $0.01	852312305
MNST	MONSTER BEVERAGE CORP NEW	4,679,308	$271,681	37.7%	$22.71	+33.4%	COM	61174X109
IWM	ISHARES TR	420,000	$63,563	8.8%	$109.78	—	RUSSELL 2000 ETF	464287655
AXON	AXON ENTERPRISE INC	760,062	$43,156	6.0%	$27.50	+129.5%	COM	05464C101
LCTX	LINEAGE CELL THERAPEUTICS IN	34,005,379	$33,325	4.6%	$1.03	0.0%	COM	53566P109
—	ONCOCYTE CORPORATION	11,098,267	$23,306	3.2%	$3.42	—	COM	68235C107
—	AGEX THERAPEUTICS INC	2,997,156	$5,874	0.8%	$2.99	—	COM	00848H108